In accordance with EFPIA’s and PhRMA´s “Principles for Responsible Clinical Trial Data Sharing” guidelines, Lundbeck is committed to responsible sharing of clinical trial data in a manner that is consistent with safeguarding the privacy of patients, respecting the integrity of national regulatory systems, and protecting the intellectual property of the sponsor. The protection of intellectual property ensures continued research and innovation in the pharmaceutical industry.
Lundbeck is committed to sharing clinical trial data from products approved in Europe and/or the United States after 1 January 2014. Detailed procedures for research proposal applications are available here: www.lundbeck.com/trials.
Lundbeck respects the privacy of the relationship between patients and healthcare professionals and is committed to ensuring that the process of scientific publication and clinical trial data sharing do not breach patient confidentiality.
